Brief: Tela Bio Sees FY Revenue Up 54 To 65 Percent
Aug 11 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO REPORTS RECORD SECOND QUARTER 2021
REVENUES DRIVEN BY
INCREASED DEMAND
* SEES FY REVENUE UP 54 TO 65 PERCENT
* SEES FY REVENUE $28 MILLION TO $30 MILLION
* Q2 REVENUE $7.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$6.3
MILLION
* QTRLY LOSS PER SHARE $0.57
* Q2 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7KyNmh
Further company coverage: TELA.O
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants